Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
Clinical trial NCT05049343 · COMPLETED
Trial details
- NCT number
- NCT05049343
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-21
- Primary completion
- 2021-11-20
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.